Clinical trial
Hidradenitis Suppurativa Patients' Experience of Treatment With Adalimumab
NCT04132388 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hidradenitis Suppurativa Patients' Experience of Treatment With Adalimumab
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- August 20, 2020
- Completion date
- September 7, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.